Hypertension Trial, Recruiting NCT07259733 Sponsor: Instituto Dante Pazzanese de Cardiologia Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07259733
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old
  • You are currently taking 3 to 5 different types of blood pressure medications, including the highest recommended dose of a specific type called an ACE inhibitor or ARB, plus a water pill (diuretic), and a calcium channel blocker
  • A 24-hour blood pressure monitoring test done within the last month showed your blood pressure is still above the target level (at or above 130/80 mmHg over 24 hours)
  • Your blood pressure measured at a clinic or doctor's office is at or above 140/90 mmHg
  • A short questionnaire about how you take your medications suggests you may sometimes have difficulty following your prescribed medication routine

Who may not be able to join:

  • Your high blood pressure is caused by an underlying medical condition, such as a hormone-producing tumour or a problem with the blood vessels near your kidneys
  • You have had a bad reaction or intolerance to certain blood pressure medications in the past, such as a persistent cough or facial swelling from ACE inhibitors, salt imbalances from water pills, or significant leg swelling or headaches from calcium channel blockers
  • You absolutely need to take a specific type of blood pressure medication called a beta-blocker or a mineralocorticoid receptor antagonist
  • Your clinic blood pressure reading is extremely high, at or above 220/120 mmHg
  • Your heart's pumping function is below a certain level, as shown on a heart scan (confirm with trial site)
  • Your kidneys are not working well enough (confirm with trial site for specific values)
  • You have an irregular heart rhythm called atrial fibrillation or atrial flutter
  • You are currently taking blood-thinning medication (anticoagulants) by mouth
  • You have a significant problem with one or more of your heart valves
  • Your body mass index (a measure of weight relative to height) is 40 or above
  • You are pregnant or currently breastfeeding
  • You have a serious psychiatric (mental health) condition
  • You have an active cancer with a life expectancy of less than 2 years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 5511996695389

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Instituto Dante Pazzanese de Cardiologia
Registry
ClinicalTrials.gov
Start date
15 July 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Rate of 24-hour Blood Pressure Control Measured by ABPM at 12 weeks; Rate of 24-hour Blood Pressure Control Measured by Ambulatory Blood Pressure Monitoring (ABPM) at 12 weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov